 | • レポートコード：MRC2305B139 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、236ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年に1,108.28百万ドルであった世界の細胞培養培地市場規模が、2022年には1,255.21百万ドルに達し、2027年までに年平均13.43％成長して2,361.04百万ドルになると予測しています。当調査資料では、細胞培養培地の世界市場について調査・分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品タイプ別分析（既知組成培地、従来型培地、溶原性培養液、無血清培地、幹細胞培地）、用途別分析（生物学的創薬、バイオ医薬品、がん研究、幹細胞技術、ヒト組織工学）、エンドユーザー別分析（学術研究機関、バイオテクノロジー産業、研究開発研究所）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの項目をまとめました。なお、当書に掲載されている企業情報には、Avantor Performance Materials、Becton, Dickinson and Company、Bio-Rad Laboratories Inc.、Cellgenix、Corning、Danaher、Dickinson and Company (BD)、Eppendorf、Fujifilm Irvine Scientific、GE Healthcare、HiMedia Laboratories Pvt., Ltd、Invivogenなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の細胞培養培地市場規模：製品タイプ別 - 既知組成培地の市場規模 - 従来型培地の市場規模 - 溶原性培養液の市場規模 - 無血清培地の市場規模 - 幹細胞培地の市場規模 ・世界の細胞培養培地市場規模：用途別 - 生物学的創薬における市場規模 - バイオ医薬品における市場規模 - がん研究における市場規模 - 幹細胞技術における市場規模 - ヒト組織工学における市場規模 ・世界の細胞培養培地市場規模：エンドユーザー別 - 学術研究機関における市場規模 - バイオテクノロジー産業における市場規模 - 研究開発研究所における市場規模 ・世界の細胞培養培地市場規模：地域別 - 南北アメリカの細胞培養培地市場規模 アメリカの細胞培養培地市場規模 カナダの細胞培養培地市場規模 ブラジルの細胞培養培地市場規模 ... - アジア太平洋の細胞培養培地市場規模 日本の細胞培養培地市場規模 中国の細胞培養培地市場規模 インドの細胞培養培地市場規模 韓国の細胞培養培地市場規模 台湾の細胞培養培地市場規模 ... - ヨーロッパ/中東/アフリカの細胞培養培地市場規模 イギリスの細胞培養培地市場規模 ドイツの細胞培養培地市場規模 フランスの細胞培養培地市場規模 ロシアの細胞培養培地市場規模 ... - その他地域の細胞培養培地市場規模 ・競争状況 ・企業情報 |
The Global Cell Culture Media Market size was estimated at USD 1,108.28 million in 2021 and expected to reach USD 1,255.21 million in 2022, and is projected to grow at a CAGR 13.43% to reach USD 2,361.04 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Cell Culture Media to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product Type, the market was studied across Chemically Defined Media, Classical Media, Lysogeny Broth, Serum-free Media, Specialty Media, and Stem Cell Media.
Based on Application, the market was studied across Biological Drug Discovery, Biopharmaceuticals, Cancer Research, Stem Cell Technologies, and Tissue Engineering.
Based on End User, the market was studied across Academic Institute, Biotechnology Industry, and Research and Development Laboratory.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cell Culture Media market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Culture Media Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Culture Media Market, including Avantor Performance Materials, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Cellgenix, Corning, Danaher, Dickinson and Company (BD), Eppendorf, Fujifilm Irvine Scientific, GE Healthcare, HiMedia Laboratories Pvt., Ltd, Invivogen, Lonza Group AG, Merck & Co., Inc., Miltenyi Biotec, Promocell, Sartorius AG, Thermo Fisher Scientific Inc., and Vitro Diagnostics, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Cell Culture Media Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Culture Media Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Culture Media Market?
4. What is the competitive strategic window for opportunities in the Global Cell Culture Media Market?
5. What are the technology trends and regulatory frameworks in the Global Cell Culture Media Market?
6. What is the market share of the leading vendors in the Global Cell Culture Media Market?
7. What modes and strategic moves are considered suitable for entering the Global Cell Culture Media Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing investment in cell culture-based vaccines
5.1.1.2. Demand for monoclonal antibodies and increased funding for cell-based research projects
5.1.1.3. Growing preference for single-use technologies
5.1.2. Restraints
5.1.2.1. High cost of cell biology research
5.1.3. Opportunities
5.1.3.1. Growing demand for 3D cell culture & personalized medicine
5.1.3.2. Need to immediately combat pandemics and communicable diseases
5.1.4. Challenges
5.1.4.1. Limited market developments in emerging economies
5.2. Cumulative Impact of COVID-19
6. Cell Culture Media Market, by Product Type
6.1. Introduction
6.2. Chemically Defined Media
6.3. Classical Media
6.4. Lysogeny Broth
6.5. Serum-free Media
6.6. Specialty Media
6.7. Stem Cell Media
7. Cell Culture Media Market, by Application
7.1. Introduction
7.2. Biological Drug Discovery
7.3. Biopharmaceuticals
7.4. Cancer Research
7.5. Stem Cell Technologies
7.6. Tissue Engineering
8. Cell Culture Media Market, by End User
8.1. Introduction
8.2. Academic Institute
8.3. Biotechnology Industry
8.4. Research and Development Laboratory
9. Americas Cell Culture Media Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cell Culture Media Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Cell Culture Media Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Avantor Performance Materials
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Becton, Dickinson and Company
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Bio-Rad Laboratories Inc.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Cellgenix
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Corning
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Danaher
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Dickinson and Company (BD)
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Eppendorf
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Fujifilm Irvine Scientific
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. GE Healthcare
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. HiMedia Laboratories Pvt., Ltd
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Invivogen
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Lonza Group AG
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Merck & Co., Inc.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Miltenyi Biotec
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Promocell
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Sartorius AG
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Thermo Fisher Scientific Inc.
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Vitro Diagnostics, Inc.
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing